Literature DB >> 18448591

Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia.

Juan Carlos Ayus1, Steven G Achinger, Allen Arieff.   

Abstract

Hyponatremia is the most common electrolyte abnormality in hospitalized patients. When symptomatic (hyponatremic encephalopathy), the overall morbidity is 34%. Individuals most susceptible to death or permanent brain damage are prepubescent children and menstruant women. Failure of the brain to adapt to the hyponatremia leads to brain damage. Major factors that can impair brain adaptation include hypoxia and peptide hormones. In children, physical factors--discrepancy between skull size and brain size--are important in the genesis of brain damage. In adults, certain hormones--estrogen and vasopressin (usually elevated in cases of hyponatremia)--have been shown to impair brain adaptation, decreasing both cerebral blood flow and oxygen utilization. Initially, hyponatremia leads to an influx of water into the brain, primarily through glial cells and largely via the water channel aquaporin (AQP)4. Water is thus shunted into astrocytes, which swell, largely preserving neuronal cell volume. The initial brain response to swelling is adaptation, utilizing the Na(+)-K(+)-ATPase system to extrude cellular Na(+). In menstruant women, estrogen + vasopressin inhibits the Na(+)-K(+)-ATPase system and decreases cerebral oxygen utilization, impairing brain adaptation. Cerebral edema compresses the respiratory centers and also forces blood out of the brain, both lowering arterial Po(2) and decreasing oxygen utilization. The hypoxemia further impairs brain adaptation. Hyponatremic encephalopathy leads to brain damage when brain adaptation is impaired and is a consequence of both cerebral hypoxia and peptide hormones.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448591     DOI: 10.1152/ajprenal.00502.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  60 in total

1.  Ecstacy-associated hyponatremia: why are women at risk?

Authors:  Michael L Moritz; Kamyar Kalantar-Zadeh; Juan Carlos Ayus
Journal:  Nephrol Dial Transplant       Date:  2013-06-26       Impact factor: 5.992

Review 2.  Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations.

Authors:  Manuel Alfredo Podestà; Irene Faravelli; David Cucchiari; Francesco Reggiani; Silvia Oldani; Carlo Fedeli; Giorgio Graziani
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

Review 3.  [Infusion therapy for neonates, infants and children].

Authors:  M A Steurer; T M Berger
Journal:  Anaesthesist       Date:  2011-01       Impact factor: 1.041

4.  Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis.

Authors:  Céline Odier; Dang Khoa Nguyen; Michel Panisset
Journal:  J Neurol       Date:  2010-02-11       Impact factor: 4.849

Review 5.  Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?

Authors:  J C Ayus; T Bellido; A L Negri
Journal:  Osteoporos Int       Date:  2017-01-10       Impact factor: 4.507

6.  Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study.

Authors:  Scott L Weiss; Luke Keele; Fran Balamuth; Neika Vendetti; Rachael Ross; Julie C Fitzgerald; Jeffrey S Gerber
Journal:  J Pediatr       Date:  2017-01-04       Impact factor: 4.406

Review 7.  Hyponatremia and bone disease.

Authors:  Armando Luis Negri; Juan Carlos Ayus
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

8.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

9.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

Review 10.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.